BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Prandi FR, Lecis D, Illuminato F, Milite M, Celotto R, Lerakis S, Romeo F, Barillà F. Epigenetic Modifications and Non-Coding RNA in Diabetes-Mellitus-Induced Coronary Artery Disease: Pathophysiological Link and New Therapeutic Frontiers. Int J Mol Sci 2022;23:4589. [PMID: 35562979 DOI: 10.3390/ijms23094589] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Vancheri C, Morini E, Prandi FR, Barillà F, Romeo F, Novelli G, Amati F. Downregulation of Circulating Hsa-miR-200c-3p Correlates with Dyslipidemia in Patients with Stable Coronary Artery Disease. Int J Mol Sci 2023;24. [PMID: 36674633 DOI: 10.3390/ijms24021112] [Reference Citation Analysis]
2 Esawy MM, Saleh Al-Sowayan N, Mobasher MA, Abd-Elhameed A, Abd Elbaser ES, Baioumy SA, Shabana MA. H19 and TUG1 lncRNAs as Novel Biomarkers for Irritable Bowel Syndrome in Diabetic Patients. Biomedicines 2022;10. [PMID: 36428545 DOI: 10.3390/biomedicines10112978] [Reference Citation Analysis]
3 Wu J, Chu E, Paul B, Kang Y. Mechanistic Studies and a Retrospective Cohort Study: The Interaction between PPAR Agonists and Immunomodulatory Agents in Multiple Myeloma. Cancers (Basel) 2022;14. [PMID: 36358696 DOI: 10.3390/cancers14215272] [Reference Citation Analysis]
4 Zafar S, Faisal S, Jan H, Ullah R, Rizwan M, Abdullah, Alotaibi A, Bibi N, Rashid AU, Khattak A. Development of Iron Nanoparticles (FeNPs) Using Biomass of Enterobacter: Its Characterization, Antimicrobial, Anti-Alzheimer's, and Enzyme Inhibition Potential. Micromachines (Basel) 2022;13:1259. [PMID: 36014181 DOI: 10.3390/mi13081259] [Reference Citation Analysis]